Clinical Trials Logo

Filter by:
NCT ID: NCT06199973 Recruiting - Clinical trials for Advanced Colorectal Cancer

Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan

Start date: March 1, 2024
Phase: Phase 3
Study type: Interventional

The study is being conducted to evaluate the efficacy, and safety of SHR-A1811 in advanced colorectal cancer subjects.

NCT ID: NCT06199895 Recruiting - Breast Cancer Clinical Trials

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Start date: November 28, 2023
Phase: Phase 2
Study type: Interventional

This study is a single-center, single-arm, open-label, phase II clinical trial designed to evaluate the efficacy and safety of Paclitaxel Polymeric Micelles for Injection for the treatment of patients with advanced pancreatic adenocarcinoma, cholangiocarcinoma, lung cancer, gastric cancer, esophageal carcinoma, or breast cancer that are resistant to Taxanes. Subjects are given paclitaxel polymeric micelles for injection, three weeks constitutes one cycle of treatment. If subject does not develop disease progression , the subject continues treatment until disease progression (RECIST 1.1) or develops an intolerable toxicity, initiation of a new anti-cancer drug, withdrawal from the study, death, or loss of follow-up. This is a single-arm, small-sample clinical study with the primary efficacy goal of objective remission rate (ORR). The parameters of the trial were set: assuming a class I error of 0.025 unilaterally, power=90%, and a 15% improvement in ORR for objective remission rate, a total of 20 subjects would be required, and a total of 25 would be required for enrolment, taking into account a 20% shedding.

NCT ID: NCT06199882 Recruiting - Clinical trials for Biliary Tract Carcinoma

SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma

Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

This is a single-arm, open, single-center Phase II clinical study to observe and evaluate the efficacy and safety of SBRT sequential surufatinib combined with immunotherapy in patients with locally unresectable or recurrent biliary tract cancer after the first surgery.

NCT ID: NCT06199856 Recruiting - Sarcopenia Clinical Trials

Assessment System for Sarcopenia Based on Ultrasonographic Data

Start date: October 1, 2020
Phase:
Study type: Observational [Patient Registry]

1. To develop an artificial intelligence assisted diagnostic model for sarcopenia based on ultrasound images; 2. To develop artificial intelligence classification and regression models for auxiliary diagnosis of sarcopenia, patient strength estimation, and other functions based on ultrasound image data.

NCT ID: NCT06199830 Completed - Asthma Clinical Trials

A Retrospective Study on the Differentiation Between Cough Variant Asthma and Chronic Cough

Start date: March 1, 2022
Phase:
Study type: Observational

this study aimed to compare characters in pulmonary function of patients with cough variant asthma and chronic cough and establish a diagnostic model.

NCT ID: NCT06199778 Terminated - Clinical trials for Traumatic Brain Injury

Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

STBI
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding (n=50) or the control group with Nasogastric tube feeding (n=48) for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared.

NCT ID: NCT06199700 Recruiting - Rett Syndrome Clinical Trials

Esketamine for the Treatment of Rett Syndrome

Start date: November 15, 2023
Phase: Early Phase 1
Study type: Interventional

The goal of this interventional study is to learn about the efficacy and safety of Esketamine for treating children with Rett syndrome (RTT). The main questions it aims to answer are: - whether Esketamine treatment is effective in improving symptom severity for RTT. - whether Esketamine is safe in the treatment of RTT. Participants will receive a weekly intravenous infusion of Esketamine for five weeks and will be assessed for disease severity and drug safety.

NCT ID: NCT06199609 Completed - Clinical trials for End Stage Renal Disease

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

Start date: September 1, 2022
Phase:
Study type: Observational

This study is a retrospective cohort study aimed at evaluating the impact of autologous arteriovenous fistula (AVF) on the heart, especially the left atrial structure, in patients with end-stage renal disease (ESRD) through a retrospective cohort study. The aim is to further clarify the relationship between the establishment of AVF and the occurrence of atrial fibrillation, and provide a theoretical basis for exploring the relevant mechanisms of AVF induced atrial fibrillation in the future.

NCT ID: NCT06199505 Enrolling by invitation - Type 2 Diabetes Clinical Trials

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects With T2DM

Start date: November 27, 2023
Phase: Phase 2
Study type: Interventional

This trial is conducted in China. The aim of the trial is to compare the efficacy and safety of GZR101 and insulin degludec/insulin aspart in insulin naïve or insulin treated subjects with type 2 diabetes.

NCT ID: NCT06199401 Not yet recruiting - Clinical trials for Complication of Surgical Procedure

Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery

ADVANCED-XJ-?
Start date: October 1, 2024
Phase: N/A
Study type: Interventional

This is a national, multicenter, open-label, randomized, controlled, endpoint-blinded clinical trial of patients diagnosed with ATAAD and undergoing "Sun's procedure" coordinated by the First Affiliated Hospital of Xi'an Jiaotong University, China. Per the protocol, "Sun's procedure" combined with "XJ-Procedure" in the anastomosis of the aortic root and Sun's procedure combined with regular suturing methods of the aortic root will be compared.